204 related articles for article (PubMed ID: 7878896)
1. Triple versus quadruple induction immunosuppression in pancreas transplantation.
Wadström J; Brekke B; Wramner L; Ekberg H; Tydén G
Transplant Proc; 1995 Feb; 27(1):1317-8. PubMed ID: 7878896
[No Abstract] [Full Text] [Related]
2. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
Schulz T; Kapischke M; Busing M
Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
[TBL] [Abstract][Full Text] [Related]
3. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
[No Abstract] [Full Text] [Related]
4. Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation.
Bruce DS; Newell KA; Woodle ES; Millis JM; Piper JB; Huss E; Thistlethwaite JR
Transplant Proc; 1996 Aug; 28(4):2136-7. PubMed ID: 8769180
[No Abstract] [Full Text] [Related]
5. OKT3 first-line treatment of acute rejection episodes following combined pancreas and kidney transplantation.
Cantarovich D; Hourmant M; Dantal J; Giral M; Paineau J; Karam G; Soulillou JP
Transplant Proc; 1994 Apr; 26(2):549. PubMed ID: 8171548
[No Abstract] [Full Text] [Related]
6. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.
Kitabayashi K; Munn SR; Sterioff S
Transplant Proc; 1996 Jun; 28(3):1973-5. PubMed ID: 8658964
[No Abstract] [Full Text] [Related]
7. Mycophenolate mofetil versus azathioprine in simultaneous pancreas-kidney transplant recipients on cyclosporine.
Fabrega AJ; Corwin CL; Hunsicker L
Transplant Proc; 1998 Jun; 30(4):1562-3. PubMed ID: 9636634
[No Abstract] [Full Text] [Related]
8. Living-related kidney transplantation using low-dose triple immunosuppression.
Rashid HU; Rahman M; Wahab MA; Kibria G; Rahman S; Jinnat S
Transplant Proc; 1994 Aug; 26(4):2089. PubMed ID: 8066680
[No Abstract] [Full Text] [Related]
9. Importance of cyclosporine dosage and blood levels in simultaneous pancreas and kidney transplant success.
Cantarovich D; Dantal J; Hourmant M; Baatard R; Paineau J; Murat A; Soulillou JP
Transplant Proc; 1992 Jun; 24(3):890-1. PubMed ID: 1604657
[No Abstract] [Full Text] [Related]
10. Tacrolimus-based vs cyclosporine-based immunotherapy in combined kidney-pancreas transplantation.
Ketel BL; Turton-Weeks S; Reed K; Barone GW
Transplant Proc; 1996 Apr; 28(2):899. PubMed ID: 8623453
[No Abstract] [Full Text] [Related]
11. Immunosuppressive requirements for small bowel/liver transplantation.
McAlister V; Grant D; Wall W; Roy A; Ghent C; Zhong R; Duff J
Transplant Proc; 1993 Feb; 25(1 Pt 2):1204-5. PubMed ID: 8442086
[No Abstract] [Full Text] [Related]
12. FK 506-based immunosuppression in clinical pancreas transplantation.
Swanson C; Rubin M; Colquhoun S; Basadonna G; Asshinnik A; Perez R
Transplant Proc; 1995 Dec; 27(6):3031. PubMed ID: 8539827
[No Abstract] [Full Text] [Related]
13. Interleukin-2 receptor antibody versus antithymocyte globulin as part of quadruple induction therapy after orthotopic liver transplantation: a randomized study.
Langrehr JM; Guckelberger O; Nüssler N; Radtke A; Lemmens HP; Jonas S; Lohmann R; Tullius S; Steinmüller T; Raakow R; Neumann U; Knoop M; Bechstein WO; Neuhaus P
Transplant Proc; 1996 Dec; 28(6):3204. PubMed ID: 8962241
[No Abstract] [Full Text] [Related]
14. Relative clinical impact of cyclosporine vs steroid induction therapy on renal function and allograft rejection in heart transplant recipients.
Hanrahan JS; Ibrahim H; Tolman D; Kirchberg D; Salter D; Guerraty A; Mohanty PK
Transplant Proc; 1996 Aug; 28(4):2107-8. PubMed ID: 8769168
[No Abstract] [Full Text] [Related]
15. Cyclosporine A blood levels predict acute rejections as well as cyclosporine A toxicity after simultaneous pancreas-kidney transplantation.
Dawidson I; Ar'Rajab A; Lu C; Melone D; Provost D; Wheeler D
Transplant Proc; 1994 Oct; 26(5):2757-8. PubMed ID: 7940868
[No Abstract] [Full Text] [Related]
16. Kidney transplantation in pediatric population.
Mota C; Henriques C; Sarmento M; Pereira E; Xavier E; Pereira M
Transplant Proc; 1994 Oct; 26(5):2768-70. PubMed ID: 7940872
[No Abstract] [Full Text] [Related]
17. High incidence of posttransplant diabetes mellitus in renal transplant recipients on triple-drug immunosuppression.
Sakhuja V; Sharma UK; Jha V; Minz M; Chugh KS
Transplant Proc; 1995 Oct; 27(5):2728-30. PubMed ID: 7482892
[No Abstract] [Full Text] [Related]
18. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG
Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
[No Abstract] [Full Text] [Related]
19. Quadruple-drug therapy with antithymocyte globulin in the early postoperative period after liver transplantation.
Schattenfroh N; Lange D; Bechstein WO; Blumhardt G; Lohmann R; Neuhaus P
Transplant Proc; 1993 Apr; 25(2):1968-9. PubMed ID: 8470245
[No Abstract] [Full Text] [Related]
20. Successful therapy of chronic renal allograft failure by enhanced immunosuppression.
Kliem V; Tiroke T; Ehlerding G; Eberhard O; Behrend M; Frei U; Koch KM; Pichlmayr R; Brunkhorst R
Transplant Proc; 1998 Jun; 30(4):1207-9. PubMed ID: 9636490
[No Abstract] [Full Text] [Related]
[Next] [New Search]
